AINDEX
Markets

NRC Health (NRC)

NRCNASDAQ-GSBiotechnology: Commercial Physical & Biological Resarch

$26.85

+0.1800 (+0.67%) today

At the close, Nov 10, 4:00 PM ET. After hours $26.85 –

+0.67% 1D
Market cap
$569.80m
P/E
30.2
EPS, last 4 quarters
$0.8900
Dividend yield
2.40%
Day range
$26.41 to $27.23
52-week range
$11.74 to $27.41
Average volume
113.4k
Previous close
$26.67

Analysts

1 covering

Buy1 buy, 0 hold, 0 sell

Targets a year out average $27.00, +0.6% from here

$27.00now $26.85$27.00

Earnings

next estimate $0.2400

Next report

Dec 2025

–

Mar 2026

–

Jun 2026

–

Sep 2026

0.0%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$35.19m$34.80m$35.39m$38.40m
Gross profit$21.26m$21.16m$21.83m$23.02m
Operating income$4.67m$5.57m-$3.24m$8.91m
Net income$1.80m$3.22m-$3.28m$4.70m

Last four quarters: revenue $143.79m, margin 4.5%, free cash flow $18.45m

News

8 latest

The company

For more than 45 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding helps leading healthcare systems get to know the patients, families, consumers, employees, and communities they serve on a human level. Guided by its uniquely empathic heritage, human-centered approach, unmatched national market research, and emphasis on consumer preferences, NRC Health is transforming the healthcare experience, creating strong outcomes across the healthcare journey.

Sector
Health Care
Industry
Biotechnology: Commercial Physical & Biological Resarch
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.